Next webinar on 18 March: The impact of COVID-19 on the content of clinical trial documentations: new requirements!
In early 2020, the US FDA and the EMA issued emergency guidance documents on how to manage clinical trials during the COVID-19 pandemic. Included in these guidances are additional requirements and documentations for ongoing clinical trials. This webinar will discuss these new requirements and share the first experiences from a medical writing perspective, with particular focus on the clinical study protocol and clinical study report. This session is aimed at medical writers and clinical researchers who are familiar with clinical trial documents.